Evidence map›Paper›PMID 41820549›Full record

ArticleNature chemical biology2026

Empowering drug innovation through fundamental RNA research in China.

Quansheng Du, Xin Wang, Yangming Wang, Mo-Fang Liu, Xiaofeng Cao

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Quansheng Du *Department of Interdisciplinary Sciences, National Natural Science Foundation of China, Beijing, China. duqs@nsfc.gov.cn.ORCID http://orcid.org/0000-0003-4300-4522
Xin Wang *Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.ORCID http://orcid.org/0000-0003-3807-9319
Yangming Wang *State Key Laboratory of Gene Function and Modulation Research, Institute of Molecular Medicine, College of Future Technology, Beijing Advanced Center of RNA Biology (BEACON), Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-6974-6060
Mo-Fang LiuKey Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China. mfliu@tongji.edu.cn.ORCID http://orcid.org/0000-0003-1800-466X
Xiaofeng CaoState Key Laboratory of Plant Genomics and National Center for Plant Gene Research, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. xfcao@genetics.ac.cn.ORCID http://orcid.org/0000-0001-9871-0753

Funding

National Natural Science Foundation of China (National Science Foundation of China) 92481001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41820549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.